Navigation Links
Combination therapy improves AIDS-related lymphoma outcome

Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.

Published in the April 1, 2006 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society, the study reveals that combination therapy showed the greatest benefit for HIV patients suffering from aggressive malignant non-Hodgkin's lymphoma. This benefit was most pronounced in HIV patients without severely impaired immune functions. These so-called "standard risk" patients responded as well to therapy and survived as long as lymphoma patients without HIV.

Lymphomas are cancers of the immune system's white blood cells. They are treated with chemotherapy, often consisting of a multi-drug regimen using cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). People with HIV, a virus that depletes integral, specialized white cells called CD-4 cells, are at increased risk of developing lymphomas, particularly aggressive, fast-growing non-Hodgkin type lymphomas. These are called "AIDS-related lymphomas" (ARL) and generally have a poorer prognosis than non-HIV-related lymphomas. Highly active antiretroviral therapy (HAART) revolutionized care of HIV-positive men and women. It not only improves laboratory indicators, such as increased CD-4 cells and reduced viral loads, but also significantly improves survival and delays the onset of AIDS and AIDS-related cancers, including lymphomas.

With the lack of study data to show the efficacy of maintaining HIV-positive patients on HAART while they are treated with chemotherapy for ARL, oncologists are hesitant to expose HIV patients to hypothetical drug toxicities related to combining the therapies. Researchers led by Rudolf Weiss, M.D., of Specialist Practice for Hematology, Oncology and Infectious Diseases
'"/>

Source:John Wiley & Sons, Inc.


Page: 1 2

Related biology news :

1. Combination therapy boosts effectiveness of telomere-directed cancer cell death
2. Combination therapy leads to partial recovery from spinal cord injury in rats
3. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
4. Combination therapy shows promising results in patients with advanced lung cancer
5. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Gene therapy converts dead bone graft to new, living tissue
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. New therapy for HIV/AIDS eliminates needles and excessive toxicity
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Combination therapy improves AIDS related lymphoma outcome

(Date:4/14/2015)... April 14, 2015  HYPR Corp. today announced ... ® ) Alliance tm , an industry consortium ... commit to share technology and collaborate to deliver ... interoperable, more secure and private, and easier to ... verification that protects sensitive user information and eliminates ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... Researchers from Massachusetts Eye and Ear, Harvard Medical ... Hospital have demonstrated, for the first time, that ... schwannomas (also known as acoustic neuromas), a sometimes ... and tinnitus. Motivated by experiments in ...
... 2014) Survivors of breast cancer have a one in ... But a study conducted in mice suggests that survivors can ... radiation to the unaffected breast at the same time that ... if it works as well in humans as in mice, ...
... Atlantic Ocean is contributing to climate change in Antarctica, a ... National Science Foundation (NSF) has concluded. Their findings ... Nature . Their work draws from more than three ... distant regional conditions are contributing to Antarctic climate change. ...
Cached Biology News:Aspirin intake may stop growth of vestibular schwannomas/acoustic neuromas 2Moderate doses of radiation therapy to unaffected breast may prevent second breast cancers 2Moderate doses of radiation therapy to unaffected breast may prevent second breast cancers 3Analysis indicates that North and tropical Atlantic warming affects Antarctic climate 2Analysis indicates that North and tropical Atlantic warming affects Antarctic climate 3
(Date:5/21/2015)... -- Imagine being able to probe and ... others. Being able to read faces and enjoy genuine ... anticipate their thoughts and actions like never before. Use ... create unique abstract paintings and video, or, play a ... first-person-shooter as it creates action, dialog, and outcomes based ...
(Date:5/21/2015)... May 20, 2015 Research and Markets ... of the "2015 Global Survey on Flow ... The primary goal of this research ... instruments and reagents. Key information the survey seeks ... of flow cytometers, predominantly used applications for flow ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/x4b7kw/top_technologies ) has announced ... Insights" report to their offering. Technical ... the Health and Wellness sector and has identified top ... in the year 2015. The research service provides an ... wellness technologies that are anticipated to have the highest ...
(Date:5/20/2015)... 20, 2015  Health eCareers, the healthcare industry,s ... with job seekers looking for the flexibility of ... mobile and online tool dedicated exclusively to temporary ... SHIFT enables employers to quickly find and ... per diem and other temporary positions, eliminating the ...
Breaking Biology Technology:5 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2Global Survey on Flow Cytometry Adoption Trends 2015 2Top Technologies in the Health and Wellness Industry 2015 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
... Contributed by G.H. Goldman, R. Geremia, M. ... , ... transformation protocols call for the addition of , ... period of exposure to DNA. However, ...
... Maren Bell and Robert Mortimer, Human Genome Center, Division,of Cell ... , Introduction ... yeast artificial chromosomes (YACs) has traditionally , ... is complicated, often unreliable, and transformation ...
... Contributed by Elizabeth Eustis-Turf*, Kiu-Mei Wang , and Lawrence , ... University of Illinois, Urbana- Champaign, ... into eukaryotic cells permits the study of many , ... ability to insert a gene into a high percentage of ...
Cached Biology Technology:Transformation of Filamentous Fungi by High-Voltage Electroporation 2Transformation of Filamentous Fungi by High-Voltage Electroporation 3Transformation of Filamentous Fungi by High-Voltage Electroporation 4Transformation of Filamentous Fungi by High-Voltage Electroporation 5Transformation of Filamentous Fungi by High-Voltage Electroporation 6Transformation of Filamentous Fungi by High-Voltage Electroporation 7Transformation of Filamentous Fungi by High-Voltage Electroporation 8Electroporation of Yeast Artificial Chromosomes 2Electroporation of Yeast Artificial Chromosomes 3Electroporation of Yeast Artificial Chromosomes 4Electroporation of Primary Bone Marrow Cells 2Electroporation of Primary Bone Marrow Cells 3Electroporation of Primary Bone Marrow Cells 4
... Microarray Slide features an ultra-thin nitrocellulose ... is the first protein microarray slide ... nitrocellulose in a thin film with ... ,The PATH™ Slide can be ...
AC input: 50-60 Hz 115-120 V...
... of DNA or Protein microarrays printed on ... slides. The proprietary design of the cassette ... as is often the case with glass ... analytical cavity volume) eliminates the need for ...
... specifically for Alkaline Phosphatase conjugates. The ... for both the enzyme and the antibody ... This product has been chemically engineered to ... longer shelf life, resistance to various shipping ...
Biology Products: